14 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 20 Phase 2, 5 Phase 3, 2 Phase 1.
Follow Esketamine: new trials by email Literature Review of Esketamine trials Research Report on Esketamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay Esketamine, Midazolam (Intravenous) - Suicidal Ideation, Suicidal Behavior | Phase 2 | Not yet recruiting | University of Sao Paulo | 106 | 2027-04-30 | 2026-10-22 |
| Ayahuasca, Esketamine and PTSD Ayahuasca, Esketamine - Posttraumatic Stress Disorder (PTSD) | Phase 2 | Recruiting | University of Sao Paulo | 10 | 2025-12-20 | 2026-01-05 |
| Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder) Esketamine (Intranasal Spray), Massed Prolonged Exposure (PE) - Post Traumatic Stress Disorder PTSD | Phase 1 / Phase 2 | Completed | The University of Texas Health Science Center at San Antonio | 4 | 2025-06-09 | 2026-01-28 |
| Effects of Esketamine Versus Magnesium Sulfate on Emotional State and Postoperative Pain in Patients Undergoing Nasal Endoscopic Surgery Esketamine, Magnesium sulfate, Saline - Chronic Rhinosinusitis, Enhanced Recovery After Surgery | Phase 1 / Phase 2 | Active not recruiting | The Second People's Hospital of Huai'an | 144 | 2025-03-01 | 2025-04-10 |
| Esketamine Combined With Pregabalin on CPSP in Spinal Patients. S-ketamine and pregabalin, Normal saline and placebo capsule - Esketamine, Pregabaline | Phase 2 / Phase 3 | Unknown | Beijing Tiantan Hospital | 150 | 2023-11-10 | 2023-11-07 |
| Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorder - 3 Month Extension Study Almond Therapy, Intranasal ketamine (Esketamine), Treatment as Usual - Treatment Resistant Major Depressive Disorder | Phase 2 | Withdrawn | Zylorion Health | 2023-01-15 | 2022-11-15 | |
| Esketamine Combined With Dexmedetomidine Sedation in Head MRI Examination of Children With Autism Spectrum Disorder low dos dexmedetomidine, high dos dexmedetomidine, dexmedetomidine and esketamine - Autism Spectrum Disorder, Dexmedetomidine | Phase 2 | Completed | Maternal and Child Health Hospital of Hubei Province | 300 | 2022-12-01 | 2024-10-09 |
| Ayahuasca and Esketamine for Major Depression Ayahuasca, Esketamine - Major Depression Severe | Phase 2 | Completed | University of Sao Paulo | 22 | 2022-10-30 | 2025-12-29 |
| Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression Psychotherapy, Treatment as Usual, Intranasal Ketamine (esketamine) - Treatment Resistant Major Depressive Disorder | Phase 2 | Terminated | Zylorion Health | 6 | 2022-10-13 | 2023-03-24 |
| Remimazolam Versus Propofol for Painless Abortion Remimazolam, Propofol, Esketamine - Anesthesia, Abortion Early | Phase 2 | Completed | Maternal and Child Health Hospital of Hubei Province | 100 | 2022-08-01 | 2022-12-02 |
| The Effect of Esketamine Combined With Pregabalin on Chronic Postsurgical Pain in Patients After Craniotomy. S-ketamine and pregabalin, Normal saline and placebo capsule - Chronic Postsurgical Pain | Phase 2 / Phase 3 | Completed | Beijing Tiantan Hospital | 246 | 2021-12-20 | 2024-08-01 |
| Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms. S-ketamine and pregabalin, Normal saline and placebo capsule - Esketamine, Pregabalin | Phase 2 / Phase 3 | Completed | Beijing Tiantan Hospital | 90 | 2021-12-01 | 2023-07-06 |
| Propofol Versus Ketamine for Rapid Sequence Intubation in Critically Ill Patients Esketamine, Propofol - Acute Respiratory Failure | Phase 2 | Completed | Federal University of São Paulo | 207 | 2021-10-23 | 2026-04-17 |
| Esketamine and Perioperative Depressive Symptoms Esketamine, Normal saline - Depressive Symptoms, Esketamine | Phase 2 / Phase 3 | Completed | Beijing Tiantan Hospital | 435 | 2021-02-19 | 2025-08-01 |
| Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide Intranasal Placebo, Midazolam Placebo Solution, Midazolam - Depressive Disorder, Major | Phase 2 | Completed | Janssen Research & Development, LLC | 147 | 2017-10-05 | 2025-04-29 |
| A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide Esketamine, Placebo - Major Depressive Disorder | Phase 2 | Completed | Janssen Research & Development, LLC | 68 | 2014-05-23 | 2025-04-29 |
| Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy Esketamine, Saline, Remifentanil - Ketamine, Anesthesia | Phase 2 | Completed | KK Women's and Children's Hospital | 90 | 2014-03-01 | 2026-08-14 |
| A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression Esketamine 14 mg, Esketamine 28 mg, Esketamine 56 mg - Treatment Resistant Depressive Disorder | Phase 2 | Completed | Janssen Research & Development, LLC | 108 | 2014-01-27 | 2025-04-29 |
| A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression Esketamine, Placebo - Major Depressive Disorder | Phase 2 | Completed | Janssen Research & Development, LLC | 30 | 2012-06-27 | 2025-04-29 |
| The Analgesic Effect of Combined Treatment With Intranasal S-ketamine and Intranasal Midazolam s-ketamine & midazolam, Morphine PCA - Analgesia, Patient-controlled, Spinal Stenosis | Phase 2 / Phase 3 | Completed | University Hospital, Basel, Switzerland | 22 | 2011-01-01 | 2013-01-29 |
Depressive Disorder, Major (3) · Pain, Postoperative (3) · Depression (2) · Depressive Disorder, Treatment-Resistant (2) · Agnosia (1) · Autism Spectrum Disorder (1) · Combat Disorders (1) · Spinal Cord Neoplasms (1) · Spinal Stenosis (1) · Stress Disorders, Post-Traumatic (1) · Suicidal Ideation (1) · Suicide Prevention (1)
Beijing Tiantan Hospital (4) · Janssen Research & Development, LLC (4) · University of Sao Paulo (3) · Maternal and Child Health Hospital of Hubei Province (2) · Zylorion Health (2) · Federal University of São Paulo (1) · KK Women's and Children's Hospital (1) · The Second People's Hospital of Huai'an (1) · The University of Texas Health Science Center at San Antonio (1) · University Hospital, Basel, Switzerland (1)
China (7) · Brazil (5) · United States (4) · Belgium (3) · Poland (2) · Bulgaria (1) · Canada (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Japan (1) · Singapore (1) · Spain (1) · Switzerland (1)
Ruquan Han, M.D., Ph D. (3) · Pierre Chue, MBBCh (2) · Casey Straud, PsyD (1) · Farida Ithnin, MBBCh (1) · Flavia R Machado, MD, PhD (1) · Linli Yue, MD (1) · Na Li, MD (1) · Raysa Schmidt, MD (1) · Ruquan Han, M.D., Ph D (1) · Wilhelm Ruppen, MD (1)
PMID 33128208, PMID 26707087, PMID 28086004, PMID 29202655, PMID 29282469, PMID 29656663, PMID 31270774, PMID 35110300, PMID 35473735, PMID 36776623, PMID 36841794, PMID 38501980, PMID 39915491, PMID 40058488, PMID 41259542, PMID 41870554, PMID 42119799
2016 (1)